Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06923098

PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS

Led by All India Institute of Medical Sciences, Bhubaneswar · Updated on 2025-04-11

108

Participants Needed

1

Research Sites

126 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Percutaneous CT guided biopsy is a well-established, standard sampling technique for suspected neoplastic lesions located in peripheral region in lung parenchyma. Inconclusive results on CT guided biopsy is substantially higher in large lung lesions which are prone to cause peripheral pneumonia, atelectasis and even regional necrosis, which are hard to be distinguished from tumor on CT images. Functional imaging guided biopsy like PET/CT guided biopsy identifies areas of highest concentration of neoplastic cells and provides accurate results. Only a few studies have been done regarding PET/CT guided biopsy and studies omparing PET/CT guided and CT guided percutaneous transthoracic lung biopsy are very few and this study would be a randomized trial comparing these diagnostic modalities in terms of diagnostic yield, diagnostic accuracy of sample and complications.

CONDITIONS

Official Title

PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age above 18 years
  • INR less than 1.2 and platelet counts greater than 80,000/mm3
  • Lung lesion larger than 10 mm on CT thorax
  • Lesions accessible for CT-guided biopsy
Not Eligible

You will not qualify if you...

  • Pre-existing bleeding disorders such as hemophilia or coagulopathy defined by INR 1.2 or higher and platelet counts 80,000/mm3 or less
  • Refusal to provide consent
  • Signs of low blood flow like hypotension or cyanosis
  • Hypoxemia with oxygen saturation below 94% measured by pulse oximeter
  • Pregnant or lactating females
  • Non-cooperative individuals
  • Lesions deemed inaccessible based on pre-biopsy planning
  • Serum creatinine level above 2 mg/dl

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

All India Institute of Medical Sciences, Bhubaneswar

Bhubaneswar, Odisha, India, 751019

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here